Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 2071802 | GCN2iB | 2183470-12-2 | 98% |  |
| GCN2iB is an ATP-competitive GCN2 inhibitory compound with a better pharmacokinetic p | ||||
| 2071625 | GRL0617 | 1093070-16-6 | 98% Min. |  |
| GRL0617 is a potent, selective and competitive noncovalent inhibitor of SARS PLPro. G | ||||
| 2071546 | GS-441524 | 1191237-69-0 | 98% Min. |  |
| GS-441524 is a potent inhibitor of feline infectious peritonitis (FIP) virus with an | ||||
| 2071533 | GSK3145095 | 1622849-43-7 | 98% Min. |  |
| GSK3145095 is a potent and orally active RIPK1 inhibitor (IC50 = 5 nM) with potential | ||||
| 2071528 | GSK2894631A | 2101626-26-8 | 98% Min. |  |
| GSK2894631A is a hematopoietic PGD synthase (HPGDS) inhibitor. | ||||
| 2071527 | GSK8612 | 2361659-62-1 | 98% Min. |  |
| GSK8612 is a potent and highly selective TBK1 inhibitor. GSK8612 inhibited recombinan | ||||
| 2071522 | GSK547 | 98% Min. |  | |
| GSK547 is a highly selective and potent inhibitor of RIP1 kinase that targets RIP1 in | ||||
| 2071511 | GSK1016790A | 942206-85-1 | 98% Min. |  |
| GSK1016790A, also known as GSK101, is a TRPV4 agonist that elicits calcium influx in | ||||
| 2071509 | GNE-131 | 1629063-81-5 | 98% Min. |  |
| GNE-131 is a Potent and Selective hNaV1.7 Inhibitor (Na V1.7 IC50 = 3 nM) for the Tre | ||||
| 2061310 | GW284543 | 790186-68-4 | 98% Min. |  |
| GW284543, also known as UNC10225170;, is a potent and selective MEK5 inhibitor with t | ||||
| 206103 | G-1 | 881639-98-1 | 98% Min. |  |
| G-1 is a selective agonist for GPER. It acts by blocking tubulin polymerization. | ||||
| 203401 | Glumetinib | 1642581-63-2 | 98% Min. |  |
| Glumetinib, also known as SCC244, is a novel, potent and highly selective inhibitor o | ||||
| 111892 | GNE-2861 | 1394121-05-1 | 98% Min. |  |
| GNE-2861 is a potent and exquisitely kinase-selective Group II PAK inhibitor (PAK4 Ki | ||||
| 193293 | GSK-199 | 1549811-53-1 | >98% |  |
| GSK199 is a selective PAD4 inhibitor with half-maximum inhibitory concentration (IC50 | ||||
| 193221 | GS-626510 | 1637770-13-8 | >98% |  |
| GS-626510 is a potent BET family bromodomains inhibitor. It acts by targeting BRD2/3/ | ||||
| 193194 | GSK2837808A | 1445879-21-9 | >98% |  |
| GSK2837808A is a potent, selective lactate dehydrogenase A (LDHA) inhibitor (IC50 val | ||||
| 193185 | GSK-963 | 2049868-46-2 | >98% |  |
| GSK-963, also known as GSK'963 or GSK963, is a potent and selective inhibitor of | ||||
| 192284 | GNE-9605 | 1536200-31-3 | >98% |  |
| GNE-9605 is a highly potent, selective, and brain-penetrant aminopyrazole leucine-ric | ||||
| 192281 | GSK3004774 | 2138814-32-9 | >98% |  |
| GSK3004774 is a potent, nonabsorbable agonist of CaSR, with an pEC50 of 7.3, 6.6 and | ||||
| 192251 | GW-3965 HCl | 405911-17-3 | >98% |  |
| GW-3965 is a liver X receptor agonist. GW3965 represses the production of pro-inflamm | ||||
| 192224 | GSK2334470 | 1227911-45-6 | >98% |  |
| GSK2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor ( | ||||
| 192201 | GSK269962 HCl | 2095432-71-4 | >98% |  |
| GSK269962 is a selective ROCK inhibitor with IC50 values of 1.6 and 6 nM for ROCK-I a | ||||
| 192194 | GW-803430 | 515141-51-2 | >98% |  |
| GW-803430 is a potent, orally active and selective melanin-concentrating hormone rece | ||||
| 192181 | GNE-477 | 1032754-81-6 | >98% |  |
| GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor. | ||||
| 191255 | GSKJ1 | 1373422-53-7 | >98% |  |
| GSKJ1 is a selective and potent histone demethylase inhibitor (GSK-J1) that has signi | ||||
| 191144 | GSK2643943A | // | >98% |  |
| GSK2643943A is a potent USP20 inhibitor with IC50 = 160 nM. | ||||
| 19185 | GSK-2807 | 2245255-65-4 | >98% |  |
| GSK-2807 is a potent and selective, SAM-competitive inhibitor of SMYD3. | ||||
| 1812291 | GNE-6640 | 2009273-67-8 | >98% |  |
| GNE-6640 is a novel selective USP7 inhibitor, inducing tumor cell death. GNE-6640 enh | ||||
| 1812102 | GSK1940029 | 1150701-66-8 | >98% |  |
| GSK1940029, also known as SCD Inhibitor 1, is a SCD Inhibitor. GSK1940029 is a potent | ||||
| 181241 | GSK2814338 | 1420367-28-7 | >98% |  |
| GSK2814338, also known as Lp-PLA2 -IN-1, is a Lp-PLA2 inhibitor. | ||||